Paperpal Prime Logo

Orphanet Journal of Rare Diseases : Impact Factor & More

eISSN: 1750-1172pISSN: 1750-1172
JournalOpen Access

Aims and Scope of Orphanet Journal of Rare Diseases

The Orphanet Journal of Rare Diseases is a peer-reviewed open access medical journal covering research on rare diseases. It was established in 2006 and the editor-in-chief is Francesc Palau (Hospital Sant Joan de Déu Barcelona and CIBERER, Spain). It is an official journal of Orphanet and is published by BioMed Central, which is part of Springer Nature. Less

Key Metrics

CiteScore
5.2
Eigenfactor
0.01 - 0.05
Impact Factor
< 5
Scite Index
0.89 5-Year SI
SJR
Q2Genetics (clinical)
SNIP
1.78
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Orphanet Journal of Rare Diseases

Orphanet Journal of Rare Diseases Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher BMC
Language English
Frequency Continuous publication
Article Processing ChargesEUR 2290 | USD 2790 | GBP 1990
Publication Time16
Editorial Review ProcessAnonymous peer review
General Details
LanguageEnglish
Society/Institute/SponsorOrphanet
FrequencyContinuous publication
Publication Start Year2006
Publisher URLVisit website
Website URLVisit website
Publication Details
Other chargesVisit website
PlagiarismVisit website
Publication Time 16
Waiver PolicyVisit website
Editorial Review Detail
Editorial TeamVisit website
Review ProcessAnonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
Deposit PolicySherpa/Romeo
License typeCC BY, CC0
OA statementVisit website
View less

Planning to publish in Orphanet Journal of Rare Diseases ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Orphanet Journal of Rare Diseases

Expiratory phase lung mechanics in late-onset Pompe disease: a multicenter study using oscillometry to identify specific breathing abnormalities.
  • 7 Aug 2026
  • Orphanet journal of rare diseases
Correction to: Quality of life in children and adults with epidermolysis bullosa: the QoL-REB explorative study
  • 7 Aug 2026
  • Orphanet Journal of Rare Diseases
Assessment of cardiometabolic risk using single point insulin sensitivity estimator (SPISE) in pediatric Bardet\u2013Biedl Syndrome: a pilot study
  • 6 Aug 2026
  • Orphanet Journal of Rare Diseases
Real world experience of carglumic acid for methylmalonic and propionic acidurias: the second interim analysis of the multicentre observational PROTECT study
  • 3 Aug 2026
  • Orphanet Journal of Rare Diseases
Management of patients with rare diseases in the Middle East: challenges & opportunities - insights from the Rare Advocacy Council.
  • 31 Jul 2026
  • Orphanet journal of rare diseases
Correction: Randomized investigation to evaluate phenylalanine fluctuation after overnight fasting in PKU patients treated with prolonged-release versus standard amino acid protein substitute.
  • 31 Jul 2026
  • Orphanet journal of rare diseases
Expiratory phase lung mechanics in late-onset Pompe disease: a multicenter study using oscillometry to identify specific breathing abnormalities.
  • 7 Aug 2026
  • Orphanet journal of rare diseases
Correction to: Quality of life in children and adults with epidermolysis bullosa: the QoL-REB explorative study
  • 7 Aug 2026
  • Orphanet Journal of Rare Diseases
Assessment of cardiometabolic risk using single point insulin sensitivity estimator (SPISE) in pediatric Bardet\u2013Biedl Syndrome: a pilot study
  • 6 Aug 2026
  • Orphanet Journal of Rare Diseases
Real world experience of carglumic acid for methylmalonic and propionic acidurias: the second interim analysis of the multicentre observational PROTECT study
  • 3 Aug 2026
  • Orphanet Journal of Rare Diseases
Management of patients with rare diseases in the Middle East: challenges & opportunities - insights from the Rare Advocacy Council.
  • 31 Jul 2026
  • Orphanet journal of rare diseases
Correction: Randomized investigation to evaluate phenylalanine fluctuation after overnight fasting in PKU patients treated with prolonged-release versus standard amino acid protein substitute.
  • 31 Jul 2026
  • Orphanet journal of rare diseases

FAQs on Orphanet Journal of Rare Diseases